Lanthanum carbonate: all 39 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Healthy Combine StudyCompletedNCT03136705Phase 1Results posted
• The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidECompletedNCT02258074Phase 2Results posted
• Phosphate Lowering in CKD TrialCompletedNCT02209636Phase 4Results posted
• A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on DialysisCompletedNCT01696279Phase 2Results posted
• Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKDCompletedNCT01128179Phase 2Results posted
• The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney DiseaseCompletedNCT01002872Not applicableResults posted
• The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy VolunteersCompletedNCT00925704Phase 1Results posted
• Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy AdultsCompletedNCT00880750Phase 1Results posted
• Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult VolunteersCompletedNCT00875017Phase 1Results posted
• Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)CompletedNCT00843349Not applicableResults posted
• A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKDCompletedNCT00785629Not applicableResults posted
• Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis PatientsCompletedNCT00660530Phase 2Results posted
• Head to Head Study Against Sevelamer HydrochlorideCompletedNCT00441545Phase 3Results posted
• Low Phosphate Diets in Patients With Early Stages of Chronic Kidney DiseaseCompletedNCT00438932Not applicableResults posted
• To Evaluate the Patient Tolerance, Pharmacodynamics and Pharmacokinetics of Lanthanum Polystyrene Sulfonate PowderStatus unknownNCT04440696Phase 1/2
• Different Effects of Non-calcium Phosphate Binders on Serum CalciumCompletedNCT03451019Phase 4
• Lanthanum Carbonate (Fosrenol®) to Reduce Oxalate Excretion in Patients With Secondary Hyperoxaluria and NephrolithiasisCompletedNCT03346369Phase 3
• A Drug Interaction Study to Evaluate the Pharmacokinetics of ASP1517 and Lanthanum Carbonate HydrateCompletedNCT02952040Phase 1
• Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and HyperphosphatemiaStatus unknownNCT02237534Phase 4
• The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23Status unknownNCT01845090Phase 4
• Fosrenol and Phosphorus Balance - Lanthanum CarbonateCompletedNCT01581996Not applicable
• Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark StudyCompletedNCT01578200Phase 3
• Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis PatientsCompletedNCT01518387Phase 3
• Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium CarbonateCompletedNCT01514851Phase 3
• Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus RestrictionStatus unknownNCT01357317Phase 3
• Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney DiseaseCompletedNCT01341678Not applicable
• Efficacy of Lanthanum Carbonate in CalciphylaxisCompletedNCT01289626Phase 1
• Long-term Study in Chronic Kidney Disease (Extension From Study 14817)CompletedNCT01187628Phase 3
• Study in Chronic Kidney Disease (CKD) Not on DialysisCompletedNCT01110629Phase 3
• BAY 77-1931 Long-term Extension From Phase II StudyCompletedNCT00769496Phase 2
• Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in BoneCompletedNCT00767637Phase 2
• Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum CarbonateCompletedNCT00458289Phase 1
• Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5TerminatedNCT00452478Phase 4
• Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney DiseaseCompletedNCT00234702Phase 2
• Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal DiseaseCompletedNCT00160121Phase 4
• Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving DialysisCompletedNCT00151931Phase 3
• Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal DiseaseCompletedNCT00151918Phase 3
• Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their BloodCompletedNCT00150566Phase 3
• A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.CompletedNCT00150540Phase 3

← Lanthanum carbonate overview